WASYL ALEXANDER MICHAEL enters NEXIEN BIOPHARMA, INC. with 5.45M shares — 100% direct ownership
Full direct ownership at entry is the strongest form of insider alignment with shareholders.
Direct
Filed: 11/1/2018ACC: 0001214659-18-006773
DirectorOfficer· Chief Executive Officer
Since Oct 2018
5.45M
Baseline shares
100% direct
5.45M
Direct ownership
1 position
0.00
Derivative underlying
0 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned5.45M
Total
5.45M direct5.45M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 5.45M | Direct |
| Total | 5.45M | 5.45M direct |
Derivative Holdings0
No derivative holdings reported